{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T10:24:55Z","timestamp":1766485495495},"reference-count":30,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic sclerosis (SSc, scleroderma) is a severe autoimmune connective tissue disease which affects the skin and internal organs. There has been evidence that coagulation factor XIII (FXIII) has a positive impact on clinical results in patients with SSc. In a single-center cohort study, we investigated the relationship between coagulation FXIII, endothelial dysfunction, and skin infection in SSc. Fifty-six patients could be included and were divided into two groups (with and without scleroderma). Markers of inflammation, coagulation, and endothelial dysfunction like C-reactive protein, leucocytes, fibrinogen, FVIII, VWF-Ag (von Willebrand factor antigen), D-dimers, and vascular endothelial growth factor were analyzed as well as MRSS (modified Rodnan skin scores) data were evaluated. Reduced daily activities were evaluated by the Scleroderma Health Assessment Questionnaire (SHAQ). There were no significant correlations between FXIII activity, MRSS, and SHAQ score. There were correlations between FXIII activity and Raynaud's phenomenon\u2013related symptoms and a weak but not significant positive correlation with the level of pain. A significant correlation between VWF-Ag and lung-associated complaints (n\u2009=\u200956; p\u2009=\u20090.41, p\u2009&lt;\u20090.0001) was found. Moreover, the study showed a correlation between VWF-Ag and MRSS (r [N\u2009=\u200948]\u2009=\u20090.4, p\u2009=\u20090.01), which means that higher VWF-Ag levels come along with more severe skin involvement. A trend toward a negative correlation between FXIII activity and VWF-Ag as marker of endothelial dysfunction was found (r [N\u2009=\u200956]\u2009=\u2009\u2212\u20090.20, p\u2009=\u20090.15). In our cohort, there is no FXIII deficiency in patients with SSc. FXIII might have a role in improving cutaneous manifestations indirectly by means of a moderating influence on endothelial dysfunction. Further clinical evaluation is needed.<\/jats:p>","DOI":"10.1055\/a-2018-7014","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T22:40:46Z","timestamp":1682980846000},"page":"411-417","source":"Crossref","is-referenced-by-count":2,"title":["Factor XIII and Endothelial Dysfunction in Patients with Systemic Sclerosis"],"prefix":"10.1055","volume":"43","author":[{"given":"Sonja","family":"Alesci","sequence":"additional","affiliation":[{"name":"Frankfurt Haemophilia Centre, Goethe University Frankfurt, Frankfurt am Main, Hessen, Germany"},{"name":"MVZ IMD GmbH Gerinnungszentrum Hochtaunus, Bad Homburg, Hessen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Wahle","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medical Clinic III, University Hospital Augsburg, Augsburg, Bayern, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Himsel","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, GPR MVZ R\u00fcsselsheim, Medical Clinic I, R\u00fcsselsheim, Hessen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Miesbach","sequence":"additional","affiliation":[{"name":"Frankfurt Haemophilia Centre, Goethe University Frankfurt, Frankfurt am Main, Hessen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/sarh.2002.50011","article-title":"Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis","volume":"32","author":"M M Cerinic","year":"2003","journal-title":"Semin Arthritis Rheum"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1590\/abd1806-4841.20152890","article-title":"Localized scleroderma: clinical spectrum and therapeutic update","volume":"90","author":"M F Careta","year":"2015","journal-title":"An Bras Dermatol"},{"issue":"02","key":"ref3","first-page":"208","article-title":"Scleroderma with an update about clinico-pathological correlation","volume":"153","author":"F Rongioletti","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1164\/rccm.201903-0563CI","article-title":"Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease","volume":"201","author":"D Khanna","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/14397595.2017.1349594","article-title":"Are there risk factors for scleroderma-related calcinosis?","volume":"28","author":"S Pai","year":"2018","journal-title":"Mod Rheumatol"},{"issue":"07","key":"ref6","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1164\/rccm.201911-2218LE","article-title":"Silica exposure and scleroderma: more bridges and collaboration between disciplines are needed","volume":"201","author":"A Lescoat","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0049-3848(93)90180-V","article-title":"Suppressive effect of human blood coagulation factor XIII on the vascular permeability induced by anti-guinea pig endothelial cell antiserum in guinea pigs","volume":"71","author":"K Hirahara","year":"1993","journal-title":"Thromb Res"},{"issue":"09","key":"ref8","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1084\/jem.189.9.1373","article-title":"Effect of factor XIII on endothelial barrier function","volume":"189","author":"T Noll","year":"1999","journal-title":"J Exp Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1749-6632.2001.tb03549.x","article-title":"Factor XIII prevents development of myocardial edema in children undergoing surgery for congenital heart disease","volume":"936","author":"G Wozniak","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00246-005-0993-5","article-title":"Plasmatic [corrected] factor XIII reduces severe pleural effusion in children after open-heart surgery","volume":"27","author":"M Schroth","year":"2006","journal-title":"Pediatr Cardiol"},{"issue":"09","key":"ref11","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCULATIONAHA.105.602094","article-title":"Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction","volume":"113","author":"M Nahrendorf","year":"2006","journal-title":"Circulation"},{"issue":"13","key":"ref12","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/emboj\/19.13.3272","article-title":"Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice","volume":"19","author":"M Streit","year":"2000","journal-title":"EMBO J"},{"issue":"08","key":"ref13","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/01.ATV.0000081636.25235.C6","article-title":"Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression","volume":"23","author":"R Dardik","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.ATV.0000154137.21230.80","article-title":"Molecular mechanisms underlying the proangiogenic effect of factor XIII","volume":"25","author":"R Dardik","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000099199","article-title":"Effect of FXIII on monocyte and fibroblast function","volume":"19","author":"R Dardik","year":"2007","journal-title":"Cell Physiol Biochem"},{"issue":"01","key":"ref16","first-page":"14","article-title":"Coagulation factor XIII, endothelial damage and systemic sclerosis","volume":"10","author":"A V Marzano","year":"2000","journal-title":"Eur J Dermatol"},{"issue":"39","key":"ref17","first-page":"2779","article-title":"Therapeutic action of coagulation factor XIII in scleroderma. 20 cases","volume":"4","author":"J Thivolet","year":"1975","journal-title":"Nouv Presse Med"},{"key":"ref18","first-page":"81","article-title":"Capillary permeability in connective tissue disease: influence of fibrogammin P-therapy","volume":"58","author":"E Pilger","year":"1987","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref19","first-page":"76","article-title":"Treatment of progressive systemic sclerosis using factor XIII","volume":"4","author":"L Guillevin","year":"1985","journal-title":"Pharmatherapeutica"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2133.1990.tb08286.x","article-title":"Factor XIII in scleroderma: in vitro studies","volume":"122","author":"M Paye","year":"1990","journal-title":"Br J Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0140-6736(81)90385-8","article-title":"Factor XIII treatment for scleroderma","volume":"2","author":"F Delbarre","year":"1981","journal-title":"Lancet"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1160\/TH14-07-0625","article-title":"Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions","volume":"113","author":"G Dickneite","year":"2015","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s41927-022-00262-2","article-title":"Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis","volume":"6","author":"P Pongkulkiat","year":"2022","journal-title":"BMC Rheumatol"},{"issue":"03","key":"ref24","first-page":"S42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"T A Medsger Jr","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11926-012-0297-8","article-title":"The immune pathogenesis of scleroderma: context is everything","volume":"15","author":"M B Greenblatt","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/archderm.1987.01660350034012","article-title":"Favorable effects of plasma factor XIII on lower esophageal sphincter pressure of progressive systemic sclerosis","volume":"123","author":"Y Maekawa","year":"1987","journal-title":"Arch Dermatol"},{"issue":"04","key":"ref27","first-page":"231","article-title":"Coagulation factor XIII in sclerodermaEur","volume":"8","author":"D Jullien","year":"1998","journal-title":"J Dermatol"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0248-8663(82)80031-3","article-title":"Traitement de la scl\u00e9rodermie g\u00e9n\u00e9ralis\u00e9e par le facteur XIII. Etude chez 25 sujets","volume":"3","author":"L Guillevin","year":"1982","journal-title":"La Revue de M\u00e9decine Interne"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1538-7836.2005.01473.x","article-title":"Factor XIII (FXIII) and angiogenesis","volume":"4","author":"R Dardik","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/art.39718","article-title":"Nailfold Videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study","volume":"68","author":"M Cutolo","year":"2016","journal-title":"Arthritis Rheumatol"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2018-7014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T23:34:28Z","timestamp":1702596868000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2018-7014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":30,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2023,12,14]]},"published-print":{"date-parts":[[2023,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2018-7014","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]}}}